Heteroaryl compounds for the treatment of pain
GEP20267935BActive Publication Date: 2026-09-10VERTEX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- GEP20267935P0
- Authority / Receiving Office
- GE · GE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-04-22
- Filing Date
- 2023-04-21
- Publication Date
- 2026-09-10
- Estimated Expiration
- 2043-04-21
Abstract
The invention relates to 1H-quinoline and naphthyridine compounds of formula (I), (I) pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising these compounds, which are used for the treatment of pain.
Need to check novelty before this filing date? Find Prior Art